Affiliation:
1. Shahid Beheshti University of Medical Sciences
2. National Heart and Lung Institute, Imperial College London
3. University of North Carolina at Chapel Hill
Abstract
Abstract
Background
Idiopathic pulmonary fibrosis (IPF) is a debilitating lung disease with poor prognosis. The fibrotic process is not fully understood but involves immune cell activation. The expression of T cell subtype-specific transcription factors involved in Th1, Th2, Th17 and T regulatory (Treg) differentiation in the pathogenesis of pulmonary fibrosis is poorly understood.
Objective
To explore the presence of T helper cell transcription factors and related cytokine profiles in IPF patients.
Methods
12 IPF patients and 8 healthy subjects (HC) were enrolled at the Masih Daneshvari Hospital, Tehran-Iran between 10–10 and 09–12 2022. Serum levels of the fibrosis-associated mediators IP-10, TNF-α, TGF-β, CXCL-8 and IFN-γ were measured by ELISA. Immunophenotyping of T helper cells combined transcription factor (T-bet, GATA-3, ROR-γt and FOXP3) presence and the intracellular expression of IL-4 and IL-17 using flow cytometry.
Results
The serum levels of TGF-β (P = 0.001), CXCL-8 (P = 0.0005), TNF-α (P = 0.0312) and IFN-γ (P = 0.0313) were significantly higher and that of IP-10 (P < 0.0001) significantly lower in IPF patients compared to HC. No significant differences in the expression of T-bet (p = 0.64), GATA3 (p = 0.63), ROR-γt (p = 0.19) and FOXP3 (p = 0.11) were found. The intracellular expression of IL-17 (P = 0.0011) was higher in IPF patients. A positive correlation between T-bet and GATA3 (P = 0.006, R = 0.738), IL-4 and ROR-γt (P = 0.044, R = 0.586) and between TNF-α with age (P = 0.007, R = 0.726) and a negative correlation between age with FOXP3 (P = 0.0017, R=-0.801) was demonstrated.
Conclusion
T-cell transcription factors were not altered in IPF patients. The expression of IP-10 may be an additional marker for IPF.
Publisher
Research Square Platform LLC